ERT is a leading provider of advanced clinical trial management systems (CTMS) and eClinical solutions, specializing in optimizing clinical trials through the integration of precision motion wearables and digital biomarkers. The company serves pharmaceutical, biotechnology, and medical device companies, focusing on improving the efficiency and accuracy of clinical trials. ERT operates in the global clinical research market, providing solutions that enhance data quality, reduce costs, and shorten study timelines. The business model revolves around offering a suite of digital tools and services, including ePRO (electronic patient-reported outcomes), eCOA (electronic clinical outcome assessments), cardiac safety, respiratory solutions, and imaging solutions. ERT generates revenue through subscription-based services, licensing fees, and consulting services. The company has supported over 15,000 studies and 5 million patients to date, contributing to 50% of all FDA approvals since 2013.

Keywords: CTMS, eClinical, digital biomarkers, precision motion wearables, ePRO, eCOA, cardiac safety, respiratory solutions, imaging solutions, clinical trials.